Human papillomavirus vaccine - EpimmuneAlternative Names: Theradigm-HPV
Latest Information Update: 16 Aug 2002
At a glance
- Originator Epimmune
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 31 Dec 1997 Discontinued - Phase-II for Human papillomavirus infections in Netherlands (SC)